It was a pleasure to host the 2nd Life Science Venture Capital Impact Day mid-April at Trill Impact offices in Stockholm. It was energizing to exchange views with leading European and US #venturecapital firms on the role of #Impactinvesting and #ESG in the early-stage life science companies. Here are my takeaways: - ESG reporting was challenged as a box-ticking exercise. How can we make it into the value adding tool it is intended to be? Collaboration between VC firms is ongoing, and I believe we will see the fruition of the work in the coming years - Impact Investing in Life Science has different definition for different VC funds and is evolving. By focusing on our common denominators, we will increase the opportunity to collaborate and tell the story of the impact we are creating together Silva Deželan, PhD, Merijn Klaassen, Robert Carroll, Beatriz Gandarias Calzada, Hannah Maunder, Roger Franklin, Noella de Bermingham, Kabeer Aziz,Patrik Sobocki (MSc, PhD), Anna Ljungdahl, Dr. Stephanie Mooij, Sarah Lafaye, Bobby Soni, Diana Torgersen, Hugues Bultot, Joachim Nahem, Eleanor Price, Dustin Zielinski, Ingrid Beyer, Linn Hege Aune, Ane Tolnes Haugdal, Johanneke Maenhout, Jan Ståhlberg, Nina Rawal,Niclas During, Ånirban Bhattachariya, PhD, MBA,
Recently, Trill Impact Ventures welcomed 15 European and US #lifescience VC investors to Stockholm, for a discussion on #impact and #ESG in early-stage life science companies. Huge thanks to all participants for sharing your insights! The opportunity to drive value creation through increased focus on #impact and #ESG matters remains large, and we were excited to see the level of engagement in this group. Trill Impact is happy to continue offering an arena for discussion ahead. For more information about the day and insights gained, visit: https://lnkd.in/dfxmXwbG Thanks to our panelists! Diana Torgersen, Joachim Nahem, Hugues Bultot Nina Rawal, Jan Ståhlberg, Bita Sehat, PhD, MBA, Niclas During & Ånirban Bhattachariya, PhD, MBA Adjuvant Capital, Aliath Bioventures, AMR Action Fund, Andera Partners, BioInnovation Institute, EQT Life Sciences, Forbion, Gilde Healthcare, Hadean Ventures, Industrifonden, Investinor, NLC Health Ventures, Sofinnova Partners, SV Health Investors, Thuja Capital, Position Green, UNIVERCELLS, Organon
Eleanor Price
6mo
Thank you again for hosting, it was a pleasure to attend, and looking forward to the continued collaboration!
Head of Responsible Investment
6moMany thanks for hosting! Good to be part of this motivated group!